ARCHIVES

In Brief: ACS Estimates 502,000 U.S. Cancer Deaths, 178,000 Avoidable With Early Diagnosis

This article is from The Cancer Letter archive.

Vol. 15 No. 11 | March 17, 1989

Download PDF Visit The Full Archive

Related Articles

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

May 13, 2005

Choice Of Reconstruction Can Depend On Who Consults

October 29, 2010

NCI-Approved Clinical Trials

July 29, 2005

Zaltrap Price Cut In Half Effective Immediately

November 8, 2012

Clinton Proposes $1.15 Billion Increase For NIH; Support For Cancer Research

January 30, 1998

NCCS Urges FDA To Finalize Regulations On Expanded Access.

December 19, 2008